Disease/Infection News

RSS

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides, Inc. (the "Company") reports that its optimized injectable FluCide® drug candidate was found to be well tolerated in a non-GLP small animal safety/toxicology study. This study is an important step in the drug development pathway for FluCide.

21 Oct 2013

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

Inovio Pharmaceuticals, Inc. announced today that the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in a phase I clinical trial in chronically HCV infected patients.

21 Oct 2013

HOYA Group's Vision Care Division expands operations in Romania

HOYA Group's Vision Care Division, a key player in the global market for ophthalmic lenses, announces the start of HOYA Lens Romania.

21 Oct 2013

Whitehead Institute scientists discover insidious nature of influenza virus

Revealing influenza's truly insidious nature, Whitehead Institute scientists have discovered that the virus is able to infect its host by first killing off the cells of the immune system that are actually best equipped to neutralize the virus.

21 Oct 2013

Researchers design surface-scanning coil detector for direct bacteria detection on food surfaces

As anyone who has ever consumed bacteria-contaminated food and experienced "food poisoning" can tell you, it's a miserable experience. Yet it's an all-too-common one, with foodborne illnesses making 1 in 6 Americans -- or 48 million people -- sick each year. Of these people sickened, 128,000 end up in the hospital, according to the Centers for Disease Control and Prevention, while 3,000 die.

19 Oct 2013

Medivir announces data from phase III studies of simeprevir in patients co-infected with HCV genotype-1 and HIV-1

Medivir AB (OMX:MVIR-B) today announced preliminary data from two phase III studies conducted by Janssen R&D Ireland evaluating simeprevir in genotype 4 chronic hepatitis C in adult patients with compensated liver disease, and in genotype 1 hepatitis C and HIV-1 co-infected adult patients.

19 Oct 2013

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), regarding its use in certain populations at high risk of pneumococcal disease.

18 Oct 2013

New study paves way for patient-specific regenerative therapies for inflammatory bowel diseases

A source of gut stem cells that can repair a type of inflammatory bowel disease when transplanted into mice has been identified by researchers at the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute at the University of Cambridge and at BRIC, the University of Copenhagen, Denmark.

18 Oct 2013

Women with common forms of urinary incontinence have various bacteria in bladder

Women with common forms of urinary incontinence have various bacteria in their bladder, according to data presented today by researchers from Loyola University Chicago Stritch School of Medicine. Researchers also found that some of these bacteria may differ based on their incontinence type.

18 Oct 2013

HBV-infected men more likely to develop liver cancer

A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer.

18 Oct 2013

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, a parasitic infection caused by the protozoan Toxoplasma gondii. They published their findings recently in PLOS Pathogens.

18 Oct 2013

Neutra working to help end staph infections in locker rooms

With football season now in full swing, a dangerous, highly resistant strain of staph infections is plaguing locker rooms across the country, potentially costing organizations such as the NFL and NCAA millions of dollars. Neutra Corp., a growing provider of all-natural wellness solutions, is working to help end the costly epidemic.

17 Oct 2013

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

AmpliPhi BioSciences Corporation, the leader in the development of bacteriophage-based antibacterial therapies to treat antibiotic resistant infections, announces it has entered into Collaboration and License Agreements with UK-based University of Leicester to develop a novel bacteriophage therapy targeting Clostridium difficile, a serious gastrointestinal infection for which new treatments are urgently required.

17 Oct 2013

Merck to present pharmacokinetic data on once-daily ISENTRESS at EACS

Merck, known as MSD outside the United States and Canada, is presenting pharmacokinetic data this week on investigational formulations of a once daily dose of ISENTRESS at the 14th European AIDS Conference, sponsored by the European AIDS Clinical Society.

17 Oct 2013

King's College researchers identify new biomarker that detects sepsis in blood

Researchers at King's College London have identified a biomarker - a biological 'fingerprint' - for sepsis in the blood, and showed it could be possible to diagnose the condition within two hours by screening for this biomarker at a patient's bedside.

17 Oct 2013

Researchers develop new microfluidic device that could speed monitoring of bacterial infections

There are good bacteria and there are bad bacteria -- and sometimes both coexist within the same species. Take, for instance, Pseudomonas aeruginosa, a microbe common in soil and water.

17 Oct 2013

Study shows narrow-spectrum UV light reduces surgical infections without damaging tissue

Despite major efforts to keep operating rooms sterile, surgical wound infections remain a serious and stubborn problem, killing up to 8,200 patients a year in the U.S. A study by Columbia University Medical Center (CUMC) researchers suggests that narrow-spectrum ultraviolet (UV) light could dramatically reduce such infections without damaging human tissue.

17 Oct 2013

Use of antibiotics to treat catheter-associated bacteriuria infection show no change in mortality rates

With 30 million indwelling bladder catheters placed annually nationwide, patients face an increased risk of developing catheter-associated bacteriuria (bacteria in the urine). Many patients with indwelling urinary catheters acquire bacteria in the urinary tract while they are catheterized.

17 Oct 2013

Duke University launches new HIV/AIDS specialty concentration within Primary Care Nurse Practitioner

Duke University School of Nursing is currently accepting applications for its new HIV/AIDS specialty concentration within the Primary Care Nurse Practitioner major for the fall 2014 semester.

17 Oct 2013

Research findings point the way to new class of antibiotics for skin and heart infections

Researchers at NYU Langone Medical Center have discovered a new mechanism by which the deadly Staphylococcus aureus bacteria attack and kill off immune cells. Their findings, published today in the journal Cell Host & Microbe, explain a critical survival tactic of a pathogen that causes more skin and heart infections than any other microbe, and kills more than 100,000 Americans every year.

17 Oct 2013

Disease/Infection News

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

HOYA Group's Vision Care Division expands operations in Romania

Whitehead Institute scientists discover insidious nature of influenza virus

Researchers design surface-scanning coil detector for direct bacteria detection on food surfaces

Medivir announces data from phase III studies of simeprevir in patients co-infected with HCV genotype-1 and HIV-1

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

New study paves way for patient-specific regenerative therapies for inflammatory bowel diseases

Women with common forms of urinary incontinence have various bacteria in bladder

HBV-infected men more likely to develop liver cancer

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Neutra working to help end staph infections in locker rooms

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

Merck to present pharmacokinetic data on once-daily ISENTRESS at EACS

King's College researchers identify new biomarker that detects sepsis in blood

Researchers develop new microfluidic device that could speed monitoring of bacterial infections

Study shows narrow-spectrum UV light reduces surgical infections without damaging tissue

Use of antibiotics to treat catheter-associated bacteriuria infection show no change in mortality rates

Duke University launches new HIV/AIDS specialty concentration within Primary Care Nurse Practitioner

Research findings point the way to new class of antibiotics for skin and heart infections

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News